Patrick J. Christmas Receives Stock Award at Regenxbio Inc (RGNX) — SEC Form 4, Jan 05, 2023

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Patrick J. Christmas

TXN 2023-01-03 · FILED 2023-01-05

Equity Position 89K sh 22,940 → 89,037

Equity Change +288.1% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Regenxbio Inc

RGNX CIK 0001590877

Reporting Owner

Name	Relationship
Patrick J. Christmas CIK 0001521123	GC

Patrick J. Christmas at Regenxbio Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Regenxbio Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2023-01-03	F - Tax Payment	1,843 D	$22.68	-$41,799	21,097	Direct
Common StockF2	2023-01-03	A - Award/Grant	67,940 A	$0.00	—	89,037	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Options (Right to buy)F3	$22.25	2023-01-03	A - Award/Grant	56,519 A	$0.00	2033-01-03	56,519 Common Stock	Direct

Footnotes (3)

F1: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022. Show more
F2: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer. Show more
F3: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Regenxbio Inc

GET /v1/forms/4/0001562180-23-000219 API docs